Senescent fibroblasts in melanoma initiation and progression: An integrated theoretical, experimental, and clinical approach

Cancer Research

Volumn 73, Issue 23, 2013, Pages 6874-6885

  Kim, Eunjung ^a   Rebecca, Vito ^b   Fedorenko, Inna V ^b   Messina, Jane L ^a   Mathew, Rahel ^a   Maria Engler, Silvya S ^c   Basanta, David ^a   Smalley, Keiran S M ^b   Anderson, Alexander R A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL INTERACTION; CELL INVASION; COMPUTER MODEL; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MELANOCYTE; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENESCENCE; SKIN FIBROBLAST; TUMOR MICROENVIRONMENT;

EID: 84890288882     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1720     Document Type: Article

References (42)

1. Andriani F, Margulis A, Lin N, Griffey S, Garlick JA. Analysis of microenvironmental factors contributing to basement membrane assembly and normalized epidermal phenotype. J Invest Dermatol 2003;120:923-31.
2. Lee DY, Cho KH. The effects of epidermal keratinocytes and dermal fibroblasts on the formation of cutaneous basement membrane in three-dimensional culture systems. Arch Dermatol Res 2005;296:296-302.
3. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003;3:559-70.
4. Miller AJ, Mihm JMC. Melanoma. N Engl J Med 2006;355:51-65.
5. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
6. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
7. Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, et al. Oncogenic BRAF induces melanocyte senescence and melanoma in mice. Cancer Cell 2009;15:294-303.
8. Michaloglou C, Vredeveld LCW, Soengas MS, Denoyelle C, Kuilman T, van der Horst CMAM, et al. BRAF V600E-associated senescence-like cell-cycle arrest of human naevi. Nature 2005;436:720-4.
9. Vredeveld LCW, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM, et al. Abrogation of BRAF V600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev 2012;26:1055-69.
10. Bhowmick N, Neilson E, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;18:332-7.
11. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002;34:1401-14.
12. Coppé J-P, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6:2853-68.
13. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 2001;98:12072-7.
14. Parrinello S, Coppe J-P, Krtolica A, Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 2005;118:485-96.
15. Laberge R-M, Awad P, Campisi J, Desprez P-Y. Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron 2012;5:39-44.
16. Adra S, Sun T, MacNeil S, Holcombe M, Smallwood R. Development of a three dimensional multiscale computational model of the human epidermis. PLoS ONE 2010;5:e8511-e.
17. Aylaj B, Luciani F, Delmas V, Larue L, De Vuyst F. Melanoblast proliferation dynamics during mouse embryonic development. Modeling and validation. J Theor Biol 2011;276:86-98.
18. Basan M, Joanny J-F, Prost J, Risler T. Undulation instability of epithelial tissues. Phys Rev Lett 2011;106:158101.
19. Chatelain C, Balois T, Ciarletta P, Ben Amar M. Emergence of microstructural patterns in skin cancer: a phase separation analysis in a binary mixture. New J Phys 2011;13:115013.
20. Ciarletta P, Foret L, Ben Amar M. The radial growth phase of malignant melanoma: multi-phase modelling, numerical simulations and linear stability analysis. J R Soc Interface 2011;8:345-68.
21. Eikenberry S, Thalhauser C, Kuang Y. Tumor-immune interaction, surgical treatment, and cancer recurrence in a mathematical model of melanoma. Plos Comput Biol 2009;5:e1000362-e.
22. Grabe N, Neuber K. A multicellular systems biology model predicts epidermal morphology, kinetics and Ca2+ flow. Bioinformatics 2005;21:3541-7.
23. Grabe N, Neuber K. Simulating psoriasis by altering transit amplifying cells. Bioinformatics 2007;23:1309-12.
24. Murphy KE, Hall CL, Maini PK, McCue SW, McElwain DLS. A fibrocontractive mechanochemical model of dermal wound closure incorporating realistic growth factor kinetics. Bull Math Biol 2012;74:1143-70.
25. Murphy KE, Hall CL, McCue SW, Sean McElwain DL. A two-compartment mechanochemical model of the roles of transforming growth factor β and tissue tension in dermal wound healing. J Theor Biol 2011;272:145-59.
26. Schaller G, Meyer-Hermann M. A modelling approach towards epidermal homoeostasis control. J Theor Biol 2007;247:554-73.
27. Suetterlin T, Huber S, Dickhaus H, Grabe N. Modeling multi-cellular behavior in epidermal tissue homeostasis via finite state machines in multi-agent systems. Bioinformatics 2009;25:2057-63.
28. Sun T, McMinn P, Holcombe M, Smallwood R. Agent based modelling helps in understanding the rules by which fibroblasts support keratinocyte colony formation. PLoS ONE 2008;3:e2129-e.
29. Thingnes J, Lavelle TJ, Hovig E, Omholt SW. Understanding the melanocyte distribution in human epidermis: an agent-based computational model approach. PLoS ONE 2012;7:e40377-e.
30. Valeyev NV, Hundhausen C, Umezawa Y, Kotov NV, Williams G, Clop A, et al. A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Comput Biol 2010;6:e1001024-e.
31. Anderson AR, Chaplain MA. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 1998;60:857-99.
32. Anderson AR, Pitairn A. Application of the Hybrid Discrete-Continuum Technique, In Polymer and cell dynamics - multiscale modeling and numerical simulations. Alt W, Chaplain M, Griebel M, Lenz J, editors. Birkhauser; 2003. p. 261-79.
33. Anderson ARA. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005;22:163-86.
34. Anderson ARA, Sleeman BD, Young IM, Griffiths BS. Nematode movement along a chemical gradient in a structurally heterogeneous environment. 2. Theory. Fundam Appl Nematol 1997;20:165-72.
35. Basanta D, Strand DW, Lukner RB, Franco OE, Cliffel DE, Ayala GE, et al. The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Res 2009;69:7111-20.
36. Brohem CA, Cardeal LB, Tiago M, Soengas MS, Barros SB, Maria-Engler SS. Artificial skin in perspective: concepts and applications. Pigment Cell Melanoma Res 2011;24:35-50.
37. Zigrino P, Nischt R, Mauch C. The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts. J Biol Chem 2011;286:6801-7.
38. Palavalli LH, Prickett TD, Wunderlich JR, Wei X, Burrell AS, Porter-Gill P, et al. Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet 2009;41:518-20.
39. Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res 2010;70:4151-62.
40. Chao C, Martin RC II, Ross MI, Reintgen DS, Edwards MJ, Noyes RD, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004;11:259-64.
41. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) based on November 2011 SEER data submission, posted to the SEER web site, April 2012. Bethesda, MD: National Cancer Institute; 2011.
42. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J Invest Dermatol 2008;128:1340-2.